What drug class is Mycamine (micafungin) in?
Mycamine (micafungin) is an echinocandin antifungal. It’s used to treat certain serious fungal infections, especially invasive Candida infections and some other invasive fungal diseases [1].
How does echinocandins like Mycamine work?
Echinocandins inhibit the fungal cell wall by blocking synthesis of 1,3-beta-D-glucan, a key structural component of many pathogenic fungi. This leads to weakened cell walls and fungal death [1].
What kinds of infections is Mycamine used for?
Mycamine is used for invasive Candida infections, and it is also used in some settings for suspected or confirmed Candida infections. Its use focuses on severe disease where an intravenous option is appropriate [1].
Where does Mycamine fit compared with other antifungal drug classes?
Common alternative antifungal classes include:
- Azoles (e.g., fluconazole, voriconazole): inhibit fungal ergosterol synthesis.
- Polyenes (e.g., amphotericin B): bind fungal cell membrane components.
- Allylamines (e.g., terbinafine): inhibit squalene epoxidation (more often for skin/nail fungi).
Mycamine’s echinocandin mechanism and intravenous use make it distinct from azoles and amphotericin B [1].
Key safety and patient questions people ask about Mycamine
Patients often ask about:
- Infusion-related reactions and monitoring during IV therapy (since it’s administered intravenously) [1].
- Liver-related lab monitoring, since antifungal therapy can affect liver tests [1].
- Whether it can be substituted with an oral antifungal (this depends on the infection type and severity, and the prescribed regimen) [1].
Sources
[1] https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Mycamine+micafungin